应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06998 亿腾嘉和
未开盘 10-13 16:08:28
1.670
-0.030
-1.76%
最高
1.675
最低
1.630
成交量
72.40万
今开
1.670
昨收
1.700
日振幅
2.65%
总市值
32.93亿
流通市值
32.93亿
总股本
19.72亿
成交额
119.93万
换手率
0.04%
流通股本
19.72亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
亿腾嘉和回购50万股股份,耗资约84.90万港元
公告速递 · 10-12 18:51
亿腾嘉和回购50万股股份,耗资约84.90万港元
亿腾嘉和(06998.HK)10月12日斥资84.9万港元回购50万股
智通财经 · 10-12 18:46
亿腾嘉和(06998.HK)10月12日斥资84.9万港元回购50万股
亿腾嘉和:GB268结直肠癌II期临床试验获批
财中社 · 10-11 18:41
亿腾嘉和:GB268结直肠癌II期临床试验获批
亿腾嘉和(06998)GB268结直肠癌II期临床试验获国家药监局批准
公告速递 · 10-11 18:21
亿腾嘉和(06998)GB268结直肠癌II期临床试验获国家药监局批准
亿腾嘉和回购88.2万股股份,涉资约148.03万港元
公告速递 · 10-08
亿腾嘉和回购88.2万股股份,涉资约148.03万港元
亿腾嘉和(06998.HK)10月8日斥资148.03万港元回购88.2万股
智通财经 · 10-08
亿腾嘉和(06998.HK)10月8日斥资148.03万港元回购88.2万股
亿腾嘉和9月股份变动月报:股本略有调整
公告速递 · 10-07
亿腾嘉和9月股份变动月报:股本略有调整
亿腾嘉和回购100万股股份,涉资约170万港元
公告速递 · 09-30
亿腾嘉和回购100万股股份,涉资约170万港元
亿腾嘉和9月29日回购100万股,耗资约169.99万港元
公告速递 · 09-29
亿腾嘉和9月29日回购100万股,耗资约169.99万港元
亿腾嘉和(06998)9月29日斥资169.99万港元回购100万股
智通财经 · 09-29
亿腾嘉和(06998)9月29日斥资169.99万港元回购100万股
亿腾嘉和回购32.7万股股份,耗资约54.94万港元
公告速递 · 09-28
亿腾嘉和回购32.7万股股份,耗资约54.94万港元
亿腾嘉和2026年中期营收8.73亿元,经调整净亏损3,285万元
公告速递 · 09-28
亿腾嘉和2026年中期营收8.73亿元,经调整净亏损3,285万元
亿腾嘉和于9月25日斥资680万港元回购400万股
新浪港股 · 09-28
亿腾嘉和于9月25日斥资680万港元回购400万股
亿腾嘉和回购400万股,耗资约680.00万港元
公告速递 · 09-25
亿腾嘉和回购400万股,耗资约680.00万港元
亿腾嘉和(06998)9月25日斥资680万港元回购400万股
智通财经 · 09-25
亿腾嘉和(06998)9月25日斥资680万港元回购400万股
亿腾嘉和:9月24日回购200万股,耗资约339.87万港元
公告速递 · 09-24
亿腾嘉和:9月24日回购200万股,耗资约339.87万港元
亿腾嘉和(06998.HK)9月24日斥资339.87万港元回购200万股
智通财经 · 09-24
亿腾嘉和(06998.HK)9月24日斥资339.87万港元回购200万股
亿腾嘉和回购412.85万股,耗资约701.84万港元
公告速递 · 09-23
亿腾嘉和回购412.85万股,耗资约701.84万港元
亿腾嘉和(06998)9月23日斥资701.84万港元回购412.85万股
智通财经网 · 09-23
亿腾嘉和(06998)9月23日斥资701.84万港元回购412.85万股
亿腾嘉和回购28.25万股股份,耗资约47.95万港元
公告速递 · 09-22
亿腾嘉和回购28.25万股股份,耗资约47.95万港元
加载更多
公司概况
公司名称:
亿腾嘉和
所属市场:
SEHK
上市日期:
--
主营业务:
亿腾嘉和医药集团有限公司(原名:嘉和生物药业(开曼)控股有限公司)是一家专注于生物制药业务的企业。该公司主营业务涵盖人用生物制药产品的研发、商业化及产业化。该公司产品管线包括来罗西利(GB491)、GB261、GB263T、英夫利西单抗(GB242)、Coprelotamab(GB221)、GB223、利妥昔单抗(GB241)等,涉及乳腺癌、肺癌、胃肠肿瘤及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06998","market":"HK","secType":"STK","nameCN":"亿腾嘉和","latestPrice":1.67,"timestamp":1791878908006,"preClose":1.7,"halted":0,"volume":724000,"delay":0,"changeRate":-0.01764705882352943,"floatShares":1972000000,"shares":1972000000,"eps":0.235,"marketStatus":"未开盘","change":-0.03,"latestTime":"10-13 16:08:28","open":1.67,"high":1.675,"low":1.63,"amount":1199347,"amplitude":0.026471,"askPrice":1.67,"askSize":23000,"bidPrice":1.65,"bidSize":13000,"shortable":3,"etf":0,"ttmEps":0.128,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":0,"adr":0,"listingDate":1602000000000,"exchange":"SEHK","adjPreClose":1.7,"openAndCloseTimeList":[[1791855000000,1791864000000],[1791867600000,1791878400000]],"volumeRatio":1.5523156092854946,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06998","defaultTab":"news","newsList":[{"id":"1193334118","title":"亿腾嘉和回购50万股股份,耗资约84.90万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193334118","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193334118?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:51","pubTimestamp":1791802270,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年10月12日发布翌日报表,公告其于当日通过香港联交所场内回购普通股50万股,占该公司回购前已发行股本约0.025%,每股回购价在1.68港元至1.70港元之间,合计耗资约84.90万港元。本次回购完成后,公司已发行股份数由1,972,059,774股降至1,971,559,774股,库藏股数量由42,066,500股增至42,566,500股,公司已发行股份总数仍为2,014,126,274股。公司表示,本次股份回购已严格遵守香港联交所上市规则及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购50万股股份,耗资约84.90万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674871198","title":"亿腾嘉和(06998.HK)10月12日斥资84.9万港元回购50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674871198","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674871198?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:46","pubTimestamp":1791802001,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06998","BK1161","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674881734","title":"亿腾嘉和:GB268结直肠癌II期临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2674881734","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674881734?lang=zh_cn&edition=full","pubTime":"2026-10-11 18:41","pubTimestamp":1791715260,"startTime":"0","endTime":"0","summary":"10月11日,亿腾嘉和(06998)发布公告,宣布其高度差异化创新的PD-1/CTLA-4/VEGF三特异性抗体GB268联合化疗在晚期结直肠癌的II期临床试验申请已于2026年10月9日获得中国国家药品监督管理局批准。这一进展标志着GB268的临床开发方案获得监管机构初步认可,为公司的后续推进奠定了坚实基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610113892081935.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610113892081935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BMED","PSYK","BK1583","BK1161","BK1574","IBBQ","06998","MDTX","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176108830","title":"亿腾嘉和(06998)GB268结直肠癌II期临床试验获国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1176108830","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176108830?lang=zh_cn&edition=full","pubTime":"2026-10-11 18:21","pubTimestamp":1791714105,"startTime":"0","endTime":"0","summary":"2026年10月11日,亿腾嘉和医药集团有限公司发布自愿公告称,其研发的PD-1/CTLA-4/VEGF三特异性抗体GB268已于2026年10月9日获得中国国家药品监督管理局批准开展针对不可根治性手术切除或局部治疗的局部晚期或转移性结直肠腺癌患者的一线联合化疗II期临床试验。这一批件意味着GB268的后续临床开发获得监管机构初步认可,为项目推进奠定基础。GB268最早于2025年7月取得NMPA首次人体临床试验批准。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166388580","title":"亿腾嘉和回购88.2万股股份,涉资约148.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166388580","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166388580?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:26","pubTimestamp":1791455162,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年10月8日发布公告,披露其当日在香港联合交易所有限公司回购股份。公司当日回购股份数量为882,000股,占该次回购前已发行股本约0.045%。回购价格区间介乎每股港币1.66港元至1.70港元,合共耗资约港币148.03万。公告显示,此次回购股份将被列为库藏股。回购完成后,公司已发行股本由原本的1,972,941,774股减少至1,972,059,774股,同期库藏股数量从41,184,500股增至42,066,500股,而公司已发行股份总数保持为2,014,126,274股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购88.2万股股份,涉资约148.03万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673281075","title":"亿腾嘉和(06998.HK)10月8日斥资148.03万港元回购88.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673281075","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673281075?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:19","pubTimestamp":1791454748,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1574","06998","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152312841","title":"亿腾嘉和9月股份变动月报:股本略有调整","url":"https://stock-news.laohu8.com/highlight/detail?id=1152312841","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152312841?lang=zh_cn&edition=full","pubTime":"2026-10-07 17:30","pubTimestamp":1791365443,"startTime":"0","endTime":"0","summary":"亿腾嘉和醫藥集團有限公司于2026年10月7日发布截至2026年9月30日的证券变动月报表。公告显示,公司法定股本维持3,000,000,000股普通股不变,每股面值USD 0.00002,总值USD 60,000。公司确认其截至本月底仍符合香港联交所对公众持股量的相关要求。其中,2019年8月19日首次公开发售前购股权计划合计因行使新增发行32,500股,2020年9月18日通过的首次公开发售后购股权计划合计因行使新增发行52,000股。此外,在2025年12月22日采纳的一次性购股权计划下,本月有4,953,574股期权失效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132602499","title":"亿腾嘉和回购100万股股份,涉资约170万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132602499","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132602499?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:23","pubTimestamp":1790760213,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年9月30日发布公告,披露公司当日在香港联交所场内回购了100万股普通股,约占当日前已发行股本的0.051%。本次回购每股价格为1.70港元,合计耗资约170万港元。根据公告,本次回购依据公司于2026年6月26日通过的股份购回授权进行,授权可回购股份总数为1.99074827亿股,截至目前共计回购1789.1万股,约占授权日已发行股本总数的0.9%。公司同时表示,本次回购已获得董事会正式授权并遵守了相关监管规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购100万股股份,涉资约170万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172846000","title":"亿腾嘉和9月29日回购100万股,耗资约169.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172846000","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172846000?lang=zh_cn&edition=full","pubTime":"2026-09-29 18:52","pubTimestamp":1790679135,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年9月29日发布翌日披露报表,宣布当日在香港联交所回购普通股1,000,000股,占回购前已发行股份总数的约0.051%。本次回购的每股价格介于1.695港元至1.70港元之间,总涉资约169.99万港元。回购完成后,公司已发行股份数量降至1,973,941,774股,库存股达40,184,500股,公司总发行股本仍为2,014,126,274股。公司已于2026年6月26日获得购回授权,可回购股份总数为199,074,827股,截至目前累计回购股份16,891,000股,占购回授权获通过当日已发行股份总数的0.85%,剩余额度为182,183,827股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和9月29日回购100万股,耗资约169.99万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671951215","title":"亿腾嘉和(06998)9月29日斥资169.99万港元回购100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671951215","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671951215?lang=zh_cn&edition=full","pubTime":"2026-09-29 18:49","pubTimestamp":1790678959,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)发布公告,于2026年9月29日,该公司斥资169.99万港元回购100万股股份,每股回购价1.695-1.7港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177420078","title":"亿腾嘉和回购32.7万股股份,耗资约54.94万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177420078","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177420078?lang=zh_cn&edition=full","pubTime":"2026-09-28 19:16","pubTimestamp":1790594191,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年9月28日发布翌日披露报表,公告在香港联交所场内回购普通股股份,共回购327,000股,占该事项前已发行股本约0.017%。回购价格为每股港币1.68元,合计耗资约54.94万港元。回购完成后,亿腾嘉和已发行股本由1,975,268,774股变更为1,974,941,774股,库藏股数量则由38,857,500股增至39,184,500股。亿腾嘉和表示,本次回购遵循香港联交所证券上市规则及相关法律要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购32.7万股股份,耗资约54.94万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132469988","title":"亿腾嘉和2026年中期营收8.73亿元,经调整净亏损3,285万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132469988","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132469988?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:39","pubTimestamp":1790584765,"startTime":"0","endTime":"0","summary":"财报显示,亿腾嘉和在2026年上半年实现营收8.73亿元,同比下降23.1%。毛利为5.78亿元,较去年同期的7.60亿元减少约24.0%,毛利率从66.9%微降至66.2%。经调整净利润为-3,285万元,而去年同期为1.58亿元,同比下滑120.96%。经营活动现金流净额为3.37亿元,相比上年同期的2.95亿元增长14.3%。财报披露,生产及分销板块于报告期内录得业绩2.76亿元,较上一期同期的2.57亿元增长7.3%。研发板块同期业绩亏损7,804万元,较上年同期的8,008万元亏损略有缩小。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"亿腾嘉和2026年中期营收8.73亿元,经调整净亏损3,285万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670040242","title":"亿腾嘉和于9月25日斥资680万港元回购400万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670040242","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670040242?lang=zh_cn&edition=full","pubTime":"2026-09-28 08:37","pubTimestamp":1790555820,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端亿腾嘉和(06998)发布公告,于2026年9月25日,该公司斥资680万港元回购400万股股份,每股回购价1.695-1.7港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-09-28/doc-initirzp9738125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1574","BK1161","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128121411","title":"亿腾嘉和回购400万股,耗资约680.00万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128121411","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128121411?lang=zh_cn&edition=full","pubTime":"2026-09-25 19:31","pubTimestamp":1790335899,"startTime":"0","endTime":"0","summary":"2026年9月25日,亿腾嘉和医药集团有限公司公告称,于当日在香港联交所场内回购普通股4,000,000股,约占回购前已发行股本的0.202%。此次回购价格介乎每股1.695港元至1.700港元,合计支付约6,799,980港元。回购前,公司于2026年9月24日的已发行股份总数为1,979,268,774股,库存股为34,857,500股。根据相关规定,自回购完成起30日内,公司不再进行任何新股发行或出售、转让库存股份,暂止期截至2026年10月25日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购400万股,耗资约680.00万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421654","title":"亿腾嘉和(06998)9月25日斥资680万港元回购400万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421654","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670421654?lang=zh_cn&edition=full","pubTime":"2026-09-25 19:29","pubTimestamp":1790335743,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)发布公告,于2026年9月25日,该公司斥资680万港元回购400万股股份,每股回购价1.695-1.7港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161413479","title":"亿腾嘉和:9月24日回购200万股,耗资约339.87万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161413479","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161413479?lang=zh_cn&edition=full","pubTime":"2026-09-24 19:40","pubTimestamp":1790250056,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年9月24日发布公告,披露公司当日通过香港联交所进行股份购回。本次回购股份数量为200万股,占当日公司已发行股本约0.101%。每股回购价格在每股1.675港元至1.700港元之间,合共支付价格约339.87万港元。回购完成后,公司已发行股份由原先的19.81268774亿股降至19.79268774亿股,库藏股份数量从3285.75万股增至3485.75万股。公司股东于2026年6月26日通过了本次购回授权,授权总数为1.99074827亿股,目前已累计回购1156.4万股,相当于该授权通过日已发行股本约0.58%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和:9月24日回购200万股,耗资约339.87万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669467593","title":"亿腾嘉和(06998.HK)9月24日斥资339.87万港元回购200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669467593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669467593?lang=zh_cn&edition=full","pubTime":"2026-09-24 19:28","pubTimestamp":1790249288,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1574","06998","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104002609","title":"亿腾嘉和回购412.85万股,耗资约701.84万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104002609","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104002609?lang=zh_cn&edition=full","pubTime":"2026-09-23 19:41","pubTimestamp":1790163688,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年9月23日在香港联合交易所回购普通股4,128,500股,约占本次回购前公司已发行股本的0.208%。本次回购价格介乎每股1.69港元至1.70港元,涉及总金额约701.84万港元。本次回购基于公司于2026年6月26日通过的购回授权,授权购回股份总数为199,074,827股,截至本次回购后已累计回购9,564,000股,占授权通过当日已发行股本约0.48%。公司董事会确认本次回购已遵守香港联合交易所有限公司证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购412.85万股,耗资约701.84万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488232","title":"亿腾嘉和(06998)9月23日斥资701.84万港元回购412.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488232","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669488232?lang=zh_cn&edition=full","pubTime":"2026-09-23 19:37","pubTimestamp":1790163470,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)发布公告,于2026年9月23日斥资701.84万港元回购412.85万股。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","BK1574","BK1583","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154335821","title":"亿腾嘉和回购28.25万股股份,耗资约47.95万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154335821","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154335821?lang=zh_cn&edition=full","pubTime":"2026-09-22 19:16","pubTimestamp":1790075785,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年9月22日在香港联交所回购股份28.25万股,占回购前公司已发行股本约0.014%。每股回购价格介乎每股1.675港元至1.70港元,总计耗资约47.95万港元。此次回购完成后,公司已发行股份总数变更为2,014,126,274股,其中1,985,397,274股为已发行股份,28,729,000股为库藏股。公司已于2026年6月26日通过有关回购股份的授权决议,可根据该授权回购股份的总数为199,074,827股。公司确认已遵守香港联交所证券上市规则及相关法律法规的要求。本公告由联席公司秘书王千惠签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购28.25万股股份,耗资约47.95万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0176},{"period":"1month","weight":-0.0176},{"period":"3month","weight":-0.165},{"period":"6month","weight":-0.4798},{"period":"1year","weight":-0.5605},{"period":"ytd","weight":-0.4433}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.0136},{"period":"6month","weight":-0.0776},{"period":"1year","weight":-0.0596},{"period":"ytd","weight":-0.0501}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亿腾嘉和医药集团有限公司(原名:嘉和生物药业(开曼)控股有限公司)是一家专注于生物制药业务的企业。该公司主营业务涵盖人用生物制药产品的研发、商业化及产业化。该公司产品管线包括来罗西利(GB491)、GB261、GB263T、英夫利西单抗(GB242)、Coprelotamab(GB221)、GB223、利妥昔单抗(GB241)等,涉及乳腺癌、肺癌、胃肠肿瘤及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.069875},{"month":2,"riseRate":0.5,"avgChangeRate":0.016786},{"month":3,"riseRate":0.5,"avgChangeRate":0.013026},{"month":4,"riseRate":0.5,"avgChangeRate":-0.068745},{"month":5,"riseRate":0.5,"avgChangeRate":-0.031387},{"month":6,"riseRate":0.5,"avgChangeRate":0.007707},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.07514},{"month":8,"riseRate":0.333333,"avgChangeRate":0.079692},{"month":9,"riseRate":0.5,"avgChangeRate":-0.065539},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.046659},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.008673},{"month":12,"riseRate":0.666667,"avgChangeRate":0.044784}],"exchange":"SEHK","name":"亿腾嘉和","nameEN":"EDDING GENOR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亿腾嘉和(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亿腾嘉和(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亿腾嘉和,06998,亿腾嘉和股票,亿腾嘉和股票老虎,亿腾嘉和股票老虎国际,亿腾嘉和行情,亿腾嘉和股票行情,亿腾嘉和股价,亿腾嘉和股市,亿腾嘉和股票价格,亿腾嘉和股票交易,亿腾嘉和股票购买,亿腾嘉和股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亿腾嘉和(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亿腾嘉和(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}